Login to Your Account



Baxter Rescues OBI-1 from Inspiration/Ipsen Alliance

By Marie Powers
Staff Writer

Friday, January 25, 2013
Inspiration Biopharmaceuticals Inc., which filed for Chapter 11 bankruptcy in November 2012, and partner Ipsen SA unloaded their lead hemophilia program, OBI-1 (recombinant porcine factor VIII), to Baxter International Inc., which boasts the market-leading resume in the hemophilia space.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription